Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

This publication has 46 references indexed in Scilit:

• Activated 3′,5′-Cyclic AMP-dependent Protein Kinase Is Sufficient to Induce Neuroendocrine-like Differentiation of the LNCaP Prostate Tumor Cell Line
  Journal of Biological Chemistry, 2000
• Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines
  The Prostate, 2000
• Neuroendocrine differentiation in prostatic carcinoma
  The Prostate, 1999
• A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
  Nature Medicine, 1999
• Characterization of the role of IL-6 in the progression of prostate cancer
  The Prostate, 1999
• ELEVATED LEVELS OF CIRCULATING INTERLEUKIN-6 AND TRANSFORMING GROWTH FACTOR-beta 1 IN PATIENTS WITH METASTATIC PROSTATIC CARCINOMA
  Journal of Urology, 1999
• Blocking signaling through the gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity
  Cancer, 1999
• Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells
  The Prostate, 1997
• Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.
  Journal of Clinical Investigation, 1995
• Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.
  Proceedings of the National Academy of Sciences, 1994